Clinical trial Recruiting at 1 site Interventional Ages 18 to 48 Women only

Comparing two local anesthetics for cesarean sections

Official title: Intrathecal Use of Chloroprocaine 1% and Ropivacaine 0,75% During Elective Cesarean Section. A Comparative Study

Run by Aretaieion University Hospital · NCT06376058 · Data updated 2026-11-12

This study is testing whether a new local anesthetic called chloroprocaine works better than the usual one, ropivacaine, for women having cesarean sections.

Quick facts

Study typeInterventional
Ages18 Years to 48 Years
SexWomen only
Enrollment60 (estimated)
SponsorAretaieion University Hospital
Academic / other
Locations1 site (Athens)
StatusRecruiting
StartedJanuary 10, 2024
Main results expectedJanuary 10, 2026
Study endsJanuary 10, 2026
Registry record updatedJuly 22, 2025
Trial IDNCT06376058 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adult women with singleton pregnancies who are scheduled for elective cesarean sections and have an ASA classification of I-II.

Probably not a fit

Patients who may not benefit from this study include those with high ASA classifications, multiple gestations, or any contraindications for regional anesthesia.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to compare the effectiveness of chloroprocaine 1% and ropivacaine 0.75% when administered intrathecally during elective cesarean sections. It is a prospective randomized study that will evaluate the anesthetic outcomes of both drugs in parturients undergoing combined spinal-epidural anesthesia. The study seeks to determine if the newer formulation of chloroprocaine, which is now considered safe, can provide advantages over the commonly used ropivacaine. The trial will include adult women with singleton pregnancies who meet specific health criteria.

Why it matters

Potential benefit: If successful, this study could provide a safer and more effective anesthetic option for women undergoing cesarean sections.

How similar studies have gone: While chloroprocaine has been used in the past, its recent reformulation makes this approach novel and untested in the context of elective cesarean sections.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* adult parturients, American Society of Anesthesiologists (ASA) I-II,
* singleton gestation\>37 weeks
* elective cesarean section

Exclusion Criteria:

* American Society of Anesthesiologists (ASA) \> III
* age \< 18 years
* singleton gestation \<37 weeks
* Body Mass Index (BMI) \>40 kg/m2
* Body weight \<50 kg
* Body weight\>100 kg
* height\<150 cm
* height\>180 cm
* multiple gestation
* emergency delivery
* fetal abnormality
* fetal distress
* pregnancy-induced pathology such as preeclampsia, eclampsia, premature labor, placental abnormalities
* pregnancy- induced diseases such as hepatic failure, pseudocholinesterase deficiency, neuromuscular diseases
* lack of informed consent
* contraindication for regional anesthesia such as thrombocytopenia, coagulation abnormalities, allergy to local anesthetics

Where it's running

  • Aretaieion University Hospital
    Athens, Greece
    Recruiting

Study contacts

  • Principal investigator: Kassiani Theodoraki, PhD, DESA — Aretaieion University Hospital
  • Study coordinator: Kassiani Theodoraki, PhD, DESA
  • Email: ktheodoraki@hotmail.com
  • Phone: 6974634162

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.